| Company/Division name | Stevanato Group |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 230 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2025 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 145 |
| Country(ies) from which reshored: | Italy |
| City reshored to: | Fishers |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | drug containment, drug delivery and diagnostic |
| What domestic positive factors made reshoring more attractive? | Proximity to customers/market |
